What is the most recent earnings date for ADMA stock?
ADMA BIOLOGICS INC (ADMA) last reported earnings on 2/25/2026.
ADMA BIOLOGICS INC (ADMA) Earnings History & Surprises
NASDAQ:ADMA • US0008991046
Current stock price
15.15 USD
+0.16 (+1.07%)
At close:
15.1063 USD
-0.04 (-0.29%)
After Hours:
ADMA Earnings overview
Past quarterly earnings results for ADMA BIOLOGICS INC (ADMA), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 5, 2026
- Period
- Q1 / 2026
- EPS Estimate
- $0.19
- Revenue Estimate
- 145.55M
Last Reported
Most Recent- Release Date
- Feb 25, 2026
- Period
- Q4 / 2025
- EPS Reported
- $0.20
- EPS Surprise
- 5.99%
- Revenue Surprise
- -2.13%
Beat Rate
Last 8 Quarters 56%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.20 | 0.19 | 5.99% | 42.86% | 139.163M | 142.19M | -2.13% | 18.39% |
| Q3 2025 | 0.15 | 0.15 | -1.96% | - | 134.224M | 133.14M | 0.81% | 12.00% |
| Q2 2025 | 0.14 | 0.14 | -1.96% | 7.69% | 121.984M | 125.12M | -2.51% | 13.80% |
| Q1 2025 | 0.11 | 0.16 | -31.17% | 37.50% | 114.802M | 118.73M | -3.31% | 40.22% |
| Q4 2024 | 0.14 | 0.15 | -8.50% | 275.00% | 117.549M | 115.06M | 2.16% | 59.06% |
| Q3 2024 | 0.15 | 0.13 | 13.12% | 1,400.00% | 119.839M | 107.97M | 10.99% | 78.13% |
| Q2 2024 | 0.13 | 0.08 | 59.31% | 533.33% | 107.191M | 88.141M | 21.61% | 78.29% |
| Q1 2024 | 0.08 | 0.06 | 42.60% | 366.67% | 81.875M | 78.821M | 3.87% | 43.86% |
| Q4 2023 | -0.08 | 0.03 | -413.73% | -33.33% | 73.904M | 73.593M | 0.42% | 47.87% |
| Q3 2023 | 0.01 | -0.01 | 230.72% | 112.50% | 67.275M | 63.368M | 6.16% | 63.72% |
| Q2 2023 | -0.03 | -0.03 | -17.65% | 57.14% | 60.123M | 56.61M | 6.21% | 77.30% |
| Q1 2023 | -0.03 | -0.04 | 30.80% | 70.00% | 56.914M | 54.477M | 4.47% | 95.58% |
| Q4 2022 | -0.06 | -0.06 | 5.88% | 33.33% | 49.98M | 46.848M | 6.69% | 89.46% |
| Q3 2022 | -0.08 | -0.08 | -1.20% | 38.46% | 41.09M | 35.174M | 16.82% | 98.69% |
| Q2 2022 | -0.07 | -0.08 | 14.22% | 50.00% | 33.91M | 32.448M | 4.51% | 90.19% |
| Q1 2022 | -0.10 | -0.09 | -15.34% | 37.50% | 29.1M | 28.713M | 1.35% | 81.31% |
| Q4 2021 | -0.09 | -0.10 | 5.46% | 55.00% | 26.38M | 22.193M | 18.87% | 88.97% |
| Q3 2021 | -0.13 | -0.15 | 11.49% | 31.58% | 20.68M | 19.1M | 8.27% | 101.17% |
| Q2 2021 | -0.14 | -0.15 | 8.50% | 39.13% | 17.83M | 16.744M | 6.49% | 128.88% |
| Q1 2021 | -0.16 | -0.17 | 5.50% | 33.33% | 16.05M | 14.87M | 7.94% | 57.35% |
| Q4 2020 | -0.20 | -0.16 | -21.66% | - | 13.96M | 13.167M | 6.02% | - |
| Q3 2020 | -0.19 | -0.19 | 0.21% | - | 10.28M | 10.159M | 1.19% | - |
| Q2 2020 | -0.23 | -0.16 | -43.62% | - | 7.79M | 10.784M | -27.76% | - |
| Q1 2020 | -0.24 | -0.13 | -90.52% | - | 10.2M | 11.093M | -8.05% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
1
Average EPS beat (4)
-7.27%
Max EPS beat (4)
5.99%
Min EPS beat (4)
-31.17%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-1.78%
Max Revenue beat (4)
0.81%
Min Revenue beat (4)
-3.31%
Analysis
In the last 4 quarters, ADMA has beaten EPS estimates in 1 out of 4 releases
ADMA has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, ADMA reported -7.3% below the EPS estimates on average.
In the last 4 quarters, ADMA reported -1.8% below the revenue estimates on average.
Related analysis
ADMA BIOLOGICS INC / ADMA Earnings FAQ
Did ADMA BIOLOGICS INC (ADMA) beat earnings estimates last quarter?
ADMA BIOLOGICS INC (ADMA) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does ADMA BIOLOGICS INC (ADMA) beat earnings estimates?
In the last 4 quarters, ADMA BIOLOGICS INC (ADMA) has beaten EPS estimates in 1 out of 4 releases.